Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2005
10/19/2005EP1354054B1 Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses
10/19/2005EP1346045B1 Human protooncogene and protein encoded therein
10/19/2005EP1345616A4 Reducing cellular damage in the human body
10/19/2005EP1339415A4 The composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator
10/19/2005EP1311263B1 Fused pyrrolocarbazoles against inflammation
10/19/2005EP1307186A4 Methods for decreasing cell proliferation based on (3r, 4r)-delta8-tetrahydrocannabinol-11-oic acids
10/19/2005EP1254131B1 Extraction of flavonoids
10/19/2005EP1250138B1 Fulvestrant formulation
10/19/2005EP1202993B1 Phenanthroline-7-one derivatives and their therapeutic uses
10/19/2005EP1200095B1 Medicament with a protective effect against oxidative-toxic substances, particularly against cardiotoxic substances
10/19/2005EP1152061B1 Method for screening physiologically active pyrrole imidazole derivative
10/19/2005EP1137946B1 Use of vascular endothelial growth factor (vegf)
10/19/2005EP1109570B1 Modulation of memory effector t-cells with a cd2 binding agent
10/19/2005EP1058679B1 Synthesis of epothilones, intermediates thereto and analogues therof
10/19/2005EP1015583B1 Protein containing an srcr domain
10/19/2005EP0966446B1 Bicyclic inhibitors of protein farnesyl transferase
10/19/2005EP0918539B1 Vaccine for b-cell malignancies
10/19/2005EP0793499B1 Method and composition for reducing tumor development with a combination of a taxane compound and a tellurium and/or selenium compound
10/19/2005EP0771208B1 Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells
10/19/2005EP0768894B1 Multi-stage cascade boosting vaccine
10/19/2005CN1685063A Methods and compositions relating to gene silencing
10/19/2005CN1684977A Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer
10/19/2005CN1684966A Novel adenine compound and use thereof
10/19/2005CN1684959A 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors
10/19/2005CN1684957A Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
10/19/2005CN1684956A Total synthesis of myriaporones
10/19/2005CN1684955A Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
10/19/2005CN1684951A Novel pyrimidineamide derivatives and the use thereof
10/19/2005CN1684948A Cytotoxic agents containing novel potent taxanes and their therapeutic use
10/19/2005CN1684702A Method of treating tumors
10/19/2005CN1684700A Gene differentially expressed in breast and bladder cancer and encoded polypeptides
10/19/2005CN1684697A Coixenolide soft capsule for treating prostatic disease
10/19/2005CN1684676A Leucine-enriched nutritional compositions
10/19/2005CN1684675A A composition comprising phytospingosine derivatives for apoptosis induction
10/19/2005CN1684673A Electrospun amorphous pharmaceutical compositions
10/19/2005CN1683532A GATA-2 mutator as one of leukemia rapid change major genes and its use
10/19/2005CN1683418A Process for preparing antrodia camphorata polysaccharide and antrodia camphorata triterpene with micro-prorous adsorptive resin and its product
10/19/2005CN1683399A Wasp antibiotic peptide and its preparing method and use
10/19/2005CN1683395A Nuclear factor-K B P65 subunit antagonistic peptide and its use
10/19/2005CN1683379A Novel liposoluble platinum (II) anti-tumor ligand
10/19/2005CN1683374A Indole carbazole alkaloid and its preparing method and use
10/19/2005CN1683366A Fatty chain end group diamine substituted hypocrellin derivative and its preparing method and use
10/19/2005CN1683344A 4-quinazolone derivative and its use in anti-tumor medicine
10/19/2005CN1683299A Metabolites of ecteinascidin 743
10/19/2005CN1683016A Process for preparing medicine-carrying particle containing surface transferrin for glioma target chemical therapy
10/19/2005CN1683005A Recombinant human granulocyte colony stimulating factor precursor liposome and its preparing method
10/19/2005CN1682988A Chinese medicine preparation for treating malignant tumor
10/19/2005CN1682981A Venom capsule for treating brain cancer
10/19/2005CN1682973A Cepharanthine oral disintegration tablet and its preparing method
10/19/2005CN1682968A Chinese medicine composition and its soft capsule
10/19/2005CN1682911A Chinese medicine for treating cancer
10/19/2005CN1682903A Method for purifying and preparing anti-tumor factor-cathepsin beta inhibiting factor from soybean or bean dregs
10/19/2005CN1682883A Sarcandra solid dispersion and its preparing method
10/19/2005CN1682879A Chinese medicine for treating apoplexy and cancer and other diseases
10/19/2005CN1682867A Medicine for treating tumor and cancer
10/19/2005CN1682864A Pure Chinese medicine compound preparation for preventing and treating cancer and malignant tumor
10/19/2005CN1682826A Chinese medicine freeze-dried powder injection for anti-tumour and its preparing method
10/19/2005CN1682816A Xiaoaiping dripping pill for treating various cancers and its preparing method
10/19/2005CN1682792A Tumor curing pill
10/19/2005CN1682790A Plaster for treating cancer and tumor
10/19/2005CN1682788A Shutongfang for killing pain and its preparation and use
10/19/2005CN1682775A Eucommia bark tablet and its preparing method
10/19/2005CN1682771A Anti-tumor active matter and its preparing method and use
10/19/2005CN1682758A Aluminium sulfate for injection and aluminium sulfate injection for treating bladder tumor
10/19/2005CN1682753A Paeonal injection emulsion for anti-tumor and its preparing method
10/19/2005CN1682752A Process for preparing lentinan drip liquid
10/19/2005CN1682751A Agaric polysaccharide freeze-dried powder injection and its preparing method
10/19/2005CN1682742A Use of 23-hydroxy betulic acid in inhibiting blood vessel formation
10/19/2005CN1682741A Anti-cancer medicine 23-hydroxy betulic acid fat emulsion and its preparing method
10/19/2005CN1682740A Use of pentacylic triterpene compounds in preparing glycogenic phosphorylase inhibitor
10/19/2005CN1682733A Anti-cancer analgetic preparation
10/19/2005CN1682730A Cepharanthine slow releasing preparation
10/19/2005CN1682726A Inclusion containing raltitrexed and preparation
10/19/2005CN1682725A Inclusion containing raltitrexed and its powder injection
10/19/2005CN1682701A Self microemulsifying preparation of curcumin and its preparing process
10/19/2005CN1682693A In site gel medicine transfer system for hardening treating angioma and vascular deformity
10/19/2005CN1223678C Pseudozoogloea particle adjuvant preparation and application
10/19/2005CN1223675C Anti tumor immunological active cell- DCIC cell, its preparing method and applications
10/19/2005CN1223607C Human calcium ion/calmodulin dependent protein kinase II inhibitory protein and its application
10/19/2005CN1223591C Piperazine oxime derivatives having Nk-1 receptor antagonistic activity
10/19/2005CN1223346C Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents
10/19/2005CN1223340C Electrospun pharmaceutical compositions
10/18/2005US6956110 Genes involved in the molecular paths of tumor suppression and/or resistance to viruses
10/18/2005US6956109 capable of crossing cell membranes, penetrating inside cells and mimicking various properties of the ceramides, particularly that of inducing apoptosis in human cancer cells
10/18/2005US6956054 Treatment of warm-blooded animals having a tumor or non-malignant hypervascularation, by administering a sufficient amount of a cytotoxic agent formulated into a phosphate prodrug form having substrate specificity for microvessel
10/18/2005US6956052 treatment of cancer and inflammation-associated disorders, such as arthritis; for example,1-[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide
10/18/2005US6956050 Imidazole compounds as anti-inflammatory and analgesic agents
10/18/2005US6956045 Anticancer agents; antiallergens; immunology diseases; antiinflamamtory agents
10/18/2005US6956041 Protein kinase inhibitors
10/18/2005US6956039 Nitrogenous heterocylic compounds
10/18/2005US6955898 Targeting pharmaceutical agents to injured tissues
10/18/2005US6955883 Life sciences business systems and methods
10/18/2005US6955818 for control of an external parasite on an animal of agricultural worth comprising 0.1 to 40% by weight of at least one spinosyn, and a non-irritant topically acceptable carrier, for example, tripropylene glycol methyl ether and benzyl alcohol
10/18/2005US6955810 Method for the treatment of inflammatory disorders
10/18/2005US6955625 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/18/2005CA2340138C 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/18/2005CA2334702C Pharmaceutical compositions and uses for androst-5-ene-3.beta.,17.beta.-diol
10/18/2005CA2331464C Platinum complex, its preparation and therapeutic application
10/18/2005CA2294171C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
10/18/2005CA2283280C Reovirus for the treatment of neoplasia
1 ... 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 ... 2211